Effects of various vehicles on the penetration of flufenamic acid into human skin

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 58, Issue 1, 2004, Pages 121-129

  Wagner, Heike ^a   Kostka, Karl Heinz ^b   Adelhardt, Willi ^b   Schaefer, Ulrich F ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Dept of Plastic and Hand Surgery ^*  (Germany)

Author keywords

DSL, deeper skin layers; FD C, Franz diffusion cell; Flufenamic acid; Franz diffusion cell; Human skin; Polyacrylate gels; Saarbruecken penetration model; SB M, Saarbruecken penetration model; SC, stratum corneum; Wool alcohol ointments

Indexed keywords

FLUFENAMIC ACID; METHANOL; POLYACRYLIC ACID;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG FORMULATION; DRUG PENETRATION; GEL; HUMAN; HUMAN TISSUE; HYDRATION; IN VITRO STUDY; LIPOPHILICITY; MICHAELIS CONSTANT; MOISTURE; PHYSICAL CHEMISTRY; PREDICTION; SKIN PENETRATION; SKIN PERMEABILITY; STEADY STATE; STRATUM CORNEUM; WATER CONTENT;

CHEMISTRY, PHARMACEUTICAL; FEMALE; FLUFENAMIC ACID; HUMANS; SKIN ABSORPTION; VEHICLES;

EID: 2942674604     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2004.03.014     Document Type: Article

References (25)

1. Roberts M.S., Walters K.A. Roberts M.S., Walters K.A. The relationship between structure and barrier function of the skin. Dermal Absorption and Toxicity Assessment. vol. 91:1998;1-42 Marcel Dekker, New York
2. Wagner H., Kostka K.H., Lehr C.-M., Schaefer U.F. Drug distribution in human skin using two different in-vitro test systems. Pharm. Res. 17:2000;1475-1481
3. Franz T.J., Lehman P.A., Franz S.F., North-Root H., Demetrulias J.L., Kelling C.K., Moloney S.J., Getting S.D. Percutaneous penetration of N-nitrosodiethanolamine through human skin (in-vitro): comparison of finite and infinite dose applications from cosmetic vehicles. Fund. Appl. Toxicol. 21:1993;213-221
4. Diembeck W., Beck H., Benech-Kiefer F., Courtellemont P., Dupuis J., Lovell W., Paye M., Sprengler J., Steilling W. Test guidance for in-vitro assessment of dermal absorption and percutaneous penetration of cosmetic ingredients. Food Chem.Toxicol. 37:1999;191-205
5. Harrison S.M., Barry B.W., Dugard P.H. Effects of freezing on human skin permeability. J. Pharm. Pharmacol. 36:1984;261-262
6. Bronaugh R.L., Stewart R.F. Methods for in vitro percutaneous absorption studies. VII. Use of excised human skin. J. Pharm. Sci. 75:1986;1094-1097
7. Wester R.C., Christoffel J., Hartway T., Poblete N., Maibach H.I., Forsell J. Human cadaver skin viability for in vitro percutaneous absorption: Storage and detrimental effects of heat-separation and freezing. Pharm. Res. 15:1998;82-84
8. Loth H. Vehicular influence on transdermal drug penetration. Int. J. Pharm. 68:1991;1-10
9. Loth H., Holle-Benninger A. Untersuchung der Arzneistoffliberation aus Salben. 1. Mitteilung: Entwicklung eines in-vitro Liberationsmodells. Pharm. Ind. 40:1978;256-261
10. Nakano M., Patel N.K. Release, uptake and permeation behaviour of salicylic acid in ointment bases. J. Pharm. Sci. 59:1970;985-988
11. Higuchi T. Physical chemical analysis of percutaneous absorption process from creams and ointments. J. Soc. Cosmetic Chem. 11:1960;85-97
12. Lippold B.C. How to optimise drug penetration through the skin. Pharm. Acta Helv. 67:1992;294-300
13. Lippold B.C. Biopharmazeutische Gesichtspunkte zur Entwicklung und Anwendung von Salben. Pharm. Ind. 38:1976;201-207
14. Ostrenga J., Steinmetz C., Poulsen B. Significance of vehicle composition. I. Relationship between topical vehicle composition, skin penetrability and clinical efficacy. J. Pharm. Sci. 60:1971;1175-1179
15. Suhonen T.M., Bouwstra J.A., Urtti A. Chemical enhancement of percutaneous absorption in relation to stratum corneum structural alterations. J. Controlled Release. 59:1999;149-161
16. Pandey R.K., Ganga S., Jayaswal S.B., Singh J. Transdermal transport of piroxicam from ointment bases. Pharmazie. 47:1992;800-801
17. Mollgaard B., Hoelgaard A. Vehicle effect on topical drug delivery. Acta Pharm. Succ. 20:1983;443-450
18. Ostrenga J., Steinmetz C., Poulsen B., Yett S. Significance of vehicle composition. II. Prediction of optimal vehicle composition. J. Pharm. Sci. 60:1971;1180-1183
19. Mayer A., Szuecs L., Toeroek J. Einfluss verschiedener Salbengrundlagen auf den perkutanen Transport eines wasserloeslichen Wirkstoffes in-vivo. Pharmazie. 33:1978;284-286
20. Kalbitz J., Neubert R., Wohlrab W. Modulation der Wirkstoffpenetration in die Haut. Pharmazie. 51:1996;619-637
21. Neubert R., Schmalfuss U., Wohlrab W., Huschka C. Wirkstoffpenetration in die Haut und deren Modulation. Pharm. Zeitung. 141:1996;11-23
22. Hadgraft J. Passive enhancement strategies in topical and transdermal drug delivery. Int. J. Pharm. 184:1999;1-6
23. Zesch A. Penetrationsbeeinflussende Faktoren bei der therapeutischen Anwendung von Externa. Pharm. Zeitung. 127:1982;2002-2007
24. F. Theobald. In-vitro Methoden zur biopharmazeutischen Qualitaetspruefung von Dermatika unter Beruecksichtigung der Lipidzusammensetzung des Stratum corneum. Dissertation Saarbruecken (1998).
25. Wagner H., Kostka K.H., Lehr C.-M., Schaefer U.F. Human skin penetration of flufenamic acid: In-vivo/in-vitro correlation (DSL) for skin samples from the same subject. J. Invest. Dermatol. 118:2002;540-544